nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90B1—gall bladder—stomach cancer	0.0222	0.0985	CbGeAlD
Rifabutin—HSP90AA1—blood vessel—stomach cancer	0.0173	0.0766	CbGeAlD
Rifabutin—HSP90AA1—gall bladder—stomach cancer	0.0163	0.0721	CbGeAlD
Rifabutin—HSP90B1—hematopoietic system—stomach cancer	0.0126	0.0558	CbGeAlD
Rifabutin—HSP90B1—epithelium—stomach cancer	0.0115	0.051	CbGeAlD
Rifabutin—HSP90B1—smooth muscle tissue—stomach cancer	0.0111	0.0491	CbGeAlD
Rifabutin—HSP90B1—pancreas—stomach cancer	0.0102	0.0454	CbGeAlD
Rifabutin—HSP90AA1—hematopoietic system—stomach cancer	0.0092	0.0408	CbGeAlD
Rifabutin—HSP90B1—lymphoid tissue—stomach cancer	0.00886	0.0393	CbGeAlD
Rifabutin—HSP90B1—digestive system—stomach cancer	0.00875	0.0388	CbGeAlD
Rifabutin—HSP90AA1—epithelium—stomach cancer	0.00841	0.0373	CbGeAlD
Rifabutin—HSP90AA1—smooth muscle tissue—stomach cancer	0.00811	0.0359	CbGeAlD
Rifabutin—HSP90B1—bone marrow—stomach cancer	0.00807	0.0358	CbGeAlD
Rifabutin—HSP90AA1—pancreas—stomach cancer	0.00749	0.0332	CbGeAlD
Rifabutin—HSP90B1—endocrine gland—stomach cancer	0.00723	0.032	CbGeAlD
Rifabutin—HSP90B1—liver—stomach cancer	0.00652	0.0289	CbGeAlD
Rifabutin—HSP90AA1—lymphoid tissue—stomach cancer	0.00648	0.0287	CbGeAlD
Rifabutin—HSP90AA1—digestive system—stomach cancer	0.0064	0.0284	CbGeAlD
Rifabutin—HSP90AA1—bone marrow—stomach cancer	0.0059	0.0261	CbGeAlD
Rifabutin—HSP90AA1—endocrine gland—stomach cancer	0.00529	0.0234	CbGeAlD
Rifabutin—HSP90B1—lymph node—stomach cancer	0.005	0.0222	CbGeAlD
Rifabutin—HSP90AA1—liver—stomach cancer	0.00477	0.0211	CbGeAlD
Rifabutin—HSP90AA1—lymph node—stomach cancer	0.00366	0.0162	CbGeAlD
Rifabutin—CYP1A2—hematopoietic system—stomach cancer	0.00298	0.0132	CbGeAlD
Rifabutin—CYP3A4—hematopoietic system—stomach cancer	0.00215	0.00954	CbGeAlD
Rifabutin—CYP1A2—digestive system—stomach cancer	0.00207	0.00917	CbGeAlD
Rifabutin—CYP1A2—endocrine gland—stomach cancer	0.00171	0.00758	CbGeAlD
Rifabutin—CYP1A2—liver—stomach cancer	0.00154	0.00683	CbGeAlD
Rifabutin—CYP3A4—digestive system—stomach cancer	0.0015	0.00664	CbGeAlD
Rifabutin—Rifampicin—CYP2A6—stomach cancer	0.00135	1	CrCbGaD
Rifabutin—CYP3A4—endocrine gland—stomach cancer	0.00124	0.00548	CbGeAlD
Rifabutin—CYP3A4—liver—stomach cancer	0.00112	0.00494	CbGeAlD
Rifabutin—Connective tissue disorder—Docetaxel—stomach cancer	0.00072	0.00217	CcSEcCtD
Rifabutin—Anorexia—Irinotecan—stomach cancer	0.000718	0.00217	CcSEcCtD
Rifabutin—Hepatitis—Capecitabine—stomach cancer	0.00071	0.00214	CcSEcCtD
Rifabutin—Thrombocytopenia—Fluorouracil—stomach cancer	0.000706	0.00213	CcSEcCtD
Rifabutin—Connective tissue disorder—Capecitabine—stomach cancer	0.000697	0.00211	CcSEcCtD
Rifabutin—Anorexia—Fluorouracil—stomach cancer	0.000688	0.00208	CcSEcCtD
Rifabutin—Eye disorder—Docetaxel—stomach cancer	0.000685	0.00207	CcSEcCtD
Rifabutin—Insomnia—Irinotecan—stomach cancer	0.000681	0.00206	CcSEcCtD
Rifabutin—Paraesthesia—Irinotecan—stomach cancer	0.000676	0.00204	CcSEcCtD
Rifabutin—Dyspnoea—Irinotecan—stomach cancer	0.000672	0.00203	CcSEcCtD
Rifabutin—Eye disorder—Capecitabine—stomach cancer	0.000663	0.002	CcSEcCtD
Rifabutin—Dyspepsia—Irinotecan—stomach cancer	0.000663	0.002	CcSEcCtD
Rifabutin—Immune system disorder—Docetaxel—stomach cancer	0.000662	0.002	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000657	0.00198	CcSEcCtD
Rifabutin—Decreased appetite—Irinotecan—stomach cancer	0.000655	0.00198	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—stomach cancer	0.000653	0.00197	CcSEcCtD
Rifabutin—Insomnia—Fluorouracil—stomach cancer	0.000652	0.00197	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00065	0.00196	CcSEcCtD
Rifabutin—Paraesthesia—Fluorouracil—stomach cancer	0.000648	0.00196	CcSEcCtD
Rifabutin—Pain—Irinotecan—stomach cancer	0.000644	0.00194	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000643	0.00194	CcSEcCtD
Rifabutin—Dyspnoea—Fluorouracil—stomach cancer	0.000643	0.00194	CcSEcCtD
Rifabutin—Immune system disorder—Capecitabine—stomach cancer	0.000641	0.00194	CcSEcCtD
Rifabutin—Dyspepsia—Fluorouracil—stomach cancer	0.000635	0.00192	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.00063	0.0019	CcSEcCtD
Rifabutin—Decreased appetite—Fluorouracil—stomach cancer	0.000627	0.00189	CcSEcCtD
Rifabutin—Pancytopenia—Methotrexate—stomach cancer	0.000627	0.00189	CcSEcCtD
Rifabutin—Dysgeusia—Docetaxel—stomach cancer	0.000625	0.00189	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000623	0.00188	CcSEcCtD
Rifabutin—Feeling abnormal—Irinotecan—stomach cancer	0.000621	0.00187	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—stomach cancer	0.000617	0.00186	CcSEcCtD
Rifabutin—Pain—Fluorouracil—stomach cancer	0.000617	0.00186	CcSEcCtD
Rifabutin—Gastrointestinal pain—Irinotecan—stomach cancer	0.000616	0.00186	CcSEcCtD
Rifabutin—Eosinophilia—Epirubicin—stomach cancer	0.000611	0.00185	CcSEcCtD
Rifabutin—Flatulence—Capecitabine—stomach cancer	0.000609	0.00184	CcSEcCtD
Rifabutin—Dysgeusia—Capecitabine—stomach cancer	0.000605	0.00183	CcSEcCtD
Rifabutin—Body temperature increased—Irinotecan—stomach cancer	0.000595	0.0018	CcSEcCtD
Rifabutin—Abdominal pain—Irinotecan—stomach cancer	0.000595	0.0018	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000595	0.0018	CcSEcCtD
Rifabutin—Feeling abnormal—Fluorouracil—stomach cancer	0.000594	0.00179	CcSEcCtD
Rifabutin—Anaemia—Docetaxel—stomach cancer	0.00059	0.00178	CcSEcCtD
Rifabutin—Pancytopenia—Epirubicin—stomach cancer	0.000587	0.00177	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000583	0.00176	CcSEcCtD
Rifabutin—Neutropenia—Epirubicin—stomach cancer	0.000578	0.00174	CcSEcCtD
Rifabutin—Leukopenia—Docetaxel—stomach cancer	0.000571	0.00172	CcSEcCtD
Rifabutin—Anaemia—Capecitabine—stomach cancer	0.000571	0.00172	CcSEcCtD
Rifabutin—Body temperature increased—Fluorouracil—stomach cancer	0.00057	0.00172	CcSEcCtD
Rifabutin—Eosinophilia—Doxorubicin—stomach cancer	0.000566	0.00171	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—stomach cancer	0.000557	0.00168	CcSEcCtD
Rifabutin—Hypersensitivity—Irinotecan—stomach cancer	0.000555	0.00168	CcSEcCtD
Rifabutin—Leukopenia—Capecitabine—stomach cancer	0.000553	0.00167	CcSEcCtD
Rifabutin—Convulsion—Docetaxel—stomach cancer	0.000553	0.00167	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—stomach cancer	0.000549	0.00166	CcSEcCtD
Rifabutin—Myalgia—Docetaxel—stomach cancer	0.000543	0.00164	CcSEcCtD
Rifabutin—Arthralgia—Docetaxel—stomach cancer	0.000543	0.00164	CcSEcCtD
Rifabutin—Chest pain—Docetaxel—stomach cancer	0.000543	0.00164	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—stomach cancer	0.000543	0.00164	CcSEcCtD
Rifabutin—Asthenia—Irinotecan—stomach cancer	0.00054	0.00163	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000539	0.00163	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—stomach cancer	0.000537	0.00162	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—stomach cancer	0.000534	0.00161	CcSEcCtD
Rifabutin—Hypersensitivity—Fluorouracil—stomach cancer	0.000532	0.0016	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—stomach cancer	0.000528	0.00159	CcSEcCtD
Rifabutin—Arthralgia—Capecitabine—stomach cancer	0.000526	0.00159	CcSEcCtD
Rifabutin—Myalgia—Capecitabine—stomach cancer	0.000526	0.00159	CcSEcCtD
Rifabutin—Chest pain—Capecitabine—stomach cancer	0.000526	0.00159	CcSEcCtD
Rifabutin—Confusional state—Docetaxel—stomach cancer	0.000525	0.00159	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000522	0.00158	CcSEcCtD
Rifabutin—Hepatobiliary disease—Epirubicin—stomach cancer	0.000521	0.00157	CcSEcCtD
Rifabutin—Diarrhoea—Irinotecan—stomach cancer	0.000515	0.00156	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—stomach cancer	0.000514	0.00155	CcSEcCtD
Rifabutin—Shock—Docetaxel—stomach cancer	0.000512	0.00155	CcSEcCtD
Rifabutin—Pruritus—Fluorouracil—stomach cancer	0.00051	0.00154	CcSEcCtD
Rifabutin—Thrombocytopenia—Docetaxel—stomach cancer	0.00051	0.00154	CcSEcCtD
Rifabutin—Confusional state—Capecitabine—stomach cancer	0.000508	0.00153	CcSEcCtD
Rifabutin—Skin disorder—Docetaxel—stomach cancer	0.000506	0.00153	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—stomach cancer	0.000497	0.0015	CcSEcCtD
Rifabutin—Anorexia—Docetaxel—stomach cancer	0.000496	0.0015	CcSEcCtD
Rifabutin—Shock—Capecitabine—stomach cancer	0.000496	0.0015	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—stomach cancer	0.000494	0.00149	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—stomach cancer	0.000494	0.00149	CcSEcCtD
Rifabutin—Diarrhoea—Fluorouracil—stomach cancer	0.000494	0.00149	CcSEcCtD
Rifabutin—Thrombocytopenia—Capecitabine—stomach cancer	0.000494	0.00149	CcSEcCtD
Rifabutin—Skin disorder—Capecitabine—stomach cancer	0.00049	0.00148	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—stomach cancer	0.000486	0.00147	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000482	0.00145	CcSEcCtD
Rifabutin—Anorexia—Capecitabine—stomach cancer	0.000481	0.00145	CcSEcCtD
Rifabutin—Vomiting—Irinotecan—stomach cancer	0.000479	0.00145	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—stomach cancer	0.000477	0.00144	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—stomach cancer	0.000475	0.00144	CcSEcCtD
Rifabutin—Rash—Irinotecan—stomach cancer	0.000475	0.00143	CcSEcCtD
Rifabutin—Dermatitis—Irinotecan—stomach cancer	0.000474	0.00143	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000474	0.00143	CcSEcCtD
Rifabutin—Headache—Irinotecan—stomach cancer	0.000472	0.00142	CcSEcCtD
Rifabutin—Insomnia—Docetaxel—stomach cancer	0.000471	0.00142	CcSEcCtD
Rifabutin—Paraesthesia—Docetaxel—stomach cancer	0.000468	0.00141	CcSEcCtD
Rifabutin—Dyspnoea—Docetaxel—stomach cancer	0.000464	0.0014	CcSEcCtD
Rifabutin—Eye disorder—Epirubicin—stomach cancer	0.000462	0.00139	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000459	0.00139	CcSEcCtD
Rifabutin—Vomiting—Fluorouracil—stomach cancer	0.000459	0.00138	CcSEcCtD
Rifabutin—Dyspepsia—Docetaxel—stomach cancer	0.000458	0.00138	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—stomach cancer	0.000457	0.00138	CcSEcCtD
Rifabutin—Insomnia—Capecitabine—stomach cancer	0.000456	0.00138	CcSEcCtD
Rifabutin—Rash—Fluorouracil—stomach cancer	0.000455	0.00137	CcSEcCtD
Rifabutin—Dermatitis—Fluorouracil—stomach cancer	0.000454	0.00137	CcSEcCtD
Rifabutin—Paraesthesia—Capecitabine—stomach cancer	0.000453	0.00137	CcSEcCtD
Rifabutin—Decreased appetite—Docetaxel—stomach cancer	0.000453	0.00137	CcSEcCtD
Rifabutin—Headache—Fluorouracil—stomach cancer	0.000452	0.00136	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—stomach cancer	0.00045	0.00136	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00045	0.00136	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—stomach cancer	0.000449	0.00136	CcSEcCtD
Rifabutin—Dyspnoea—Capecitabine—stomach cancer	0.000449	0.00136	CcSEcCtD
Rifabutin—Nausea—Irinotecan—stomach cancer	0.000447	0.00135	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—stomach cancer	0.000447	0.00135	CcSEcCtD
Rifabutin—Pain—Docetaxel—stomach cancer	0.000445	0.00134	CcSEcCtD
Rifabutin—Dyspepsia—Capecitabine—stomach cancer	0.000444	0.00134	CcSEcCtD
Rifabutin—Decreased appetite—Capecitabine—stomach cancer	0.000438	0.00132	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000435	0.00131	CcSEcCtD
Rifabutin—Pain—Capecitabine—stomach cancer	0.000431	0.0013	CcSEcCtD
Rifabutin—Feeling abnormal—Docetaxel—stomach cancer	0.000429	0.0013	CcSEcCtD
Rifabutin—Nausea—Fluorouracil—stomach cancer	0.000429	0.00129	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—stomach cancer	0.000427	0.00129	CcSEcCtD
Rifabutin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000426	0.00129	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—stomach cancer	0.000425	0.00128	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—stomach cancer	0.000424	0.00128	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—stomach cancer	0.000421	0.00127	CcSEcCtD
Rifabutin—Feeling abnormal—Capecitabine—stomach cancer	0.000415	0.00125	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—stomach cancer	0.000413	0.00125	CcSEcCtD
Rifabutin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000412	0.00124	CcSEcCtD
Rifabutin—Abdominal pain—Docetaxel—stomach cancer	0.000412	0.00124	CcSEcCtD
Rifabutin—Body temperature increased—Docetaxel—stomach cancer	0.000412	0.00124	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—stomach cancer	0.000412	0.00124	CcSEcCtD
Rifabutin—Abdominal pain—Capecitabine—stomach cancer	0.000399	0.0012	CcSEcCtD
Rifabutin—Body temperature increased—Capecitabine—stomach cancer	0.000399	0.0012	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—stomach cancer	0.000398	0.0012	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—stomach cancer	0.000398	0.0012	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—stomach cancer	0.000392	0.00118	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—stomach cancer	0.000391	0.00118	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—stomach cancer	0.000391	0.00118	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—stomach cancer	0.000391	0.00118	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—stomach cancer	0.00039	0.00118	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000389	0.00117	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—stomach cancer	0.000385	0.00116	CcSEcCtD
Rifabutin—Hypersensitivity—Docetaxel—stomach cancer	0.000384	0.00116	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—stomach cancer	0.000378	0.00114	CcSEcCtD
Rifabutin—Asthenia—Docetaxel—stomach cancer	0.000374	0.00113	CcSEcCtD
Rifabutin—Convulsion—Epirubicin—stomach cancer	0.000373	0.00113	CcSEcCtD
Rifabutin—Hypersensitivity—Capecitabine—stomach cancer	0.000371	0.00112	CcSEcCtD
Rifabutin—Pruritus—Docetaxel—stomach cancer	0.000368	0.00111	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—stomach cancer	0.000368	0.00111	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—stomach cancer	0.000367	0.00111	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—stomach cancer	0.000366	0.00111	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—stomach cancer	0.000366	0.00111	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—stomach cancer	0.000366	0.00111	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—stomach cancer	0.000365	0.0011	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000364	0.0011	CcSEcCtD
Rifabutin—Asthenia—Capecitabine—stomach cancer	0.000362	0.00109	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—stomach cancer	0.000358	0.00108	CcSEcCtD
Rifabutin—Pruritus—Capecitabine—stomach cancer	0.000357	0.00108	CcSEcCtD
Rifabutin—Leukopenia—Doxorubicin—stomach cancer	0.000356	0.00108	CcSEcCtD
Rifabutin—Diarrhoea—Docetaxel—stomach cancer	0.000356	0.00108	CcSEcCtD
Rifabutin—Confusional state—Epirubicin—stomach cancer	0.000354	0.00107	CcSEcCtD
Rifabutin—Shock—Epirubicin—stomach cancer	0.000346	0.00104	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—stomach cancer	0.000345	0.00104	CcSEcCtD
Rifabutin—Diarrhoea—Capecitabine—stomach cancer	0.000345	0.00104	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—stomach cancer	0.000344	0.00104	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000342	0.00103	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—stomach cancer	0.000341	0.00103	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—stomach cancer	0.000339	0.00102	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—stomach cancer	0.000339	0.00102	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—stomach cancer	0.000339	0.00102	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—stomach cancer	0.000339	0.00102	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—stomach cancer	0.000337	0.00102	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000337	0.00102	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—stomach cancer	0.000335	0.00101	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—stomach cancer	0.000335	0.00101	CcSEcCtD
Rifabutin—Vomiting—Docetaxel—stomach cancer	0.000331	0.001	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—stomach cancer	0.00033	0.000997	CcSEcCtD
Rifabutin—Rash—Docetaxel—stomach cancer	0.000328	0.000991	CcSEcCtD
Rifabutin—Dermatitis—Docetaxel—stomach cancer	0.000328	0.00099	CcSEcCtD
Rifabutin—Confusional state—Doxorubicin—stomach cancer	0.000328	0.000989	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—stomach cancer	0.000326	0.000985	CcSEcCtD
Rifabutin—Headache—Docetaxel—stomach cancer	0.000326	0.000985	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000324	0.000978	CcSEcCtD
Rifabutin—Pain—Methotrexate—stomach cancer	0.000321	0.000969	CcSEcCtD
Rifabutin—Vomiting—Capecitabine—stomach cancer	0.000321	0.000968	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00032	0.000966	CcSEcCtD
Rifabutin—Shock—Doxorubicin—stomach cancer	0.00032	0.000965	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000318	0.000961	CcSEcCtD
Rifabutin—Rash—Capecitabine—stomach cancer	0.000318	0.00096	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—stomach cancer	0.000318	0.000959	CcSEcCtD
Rifabutin—Dermatitis—Capecitabine—stomach cancer	0.000318	0.000959	CcSEcCtD
Rifabutin—Headache—Capecitabine—stomach cancer	0.000316	0.000954	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—stomach cancer	0.000316	0.000953	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—stomach cancer	0.000315	0.000952	CcSEcCtD
Rifabutin—Dyspnoea—Epirubicin—stomach cancer	0.000313	0.000945	CcSEcCtD
Rifabutin—Anorexia—Doxorubicin—stomach cancer	0.00031	0.000935	CcSEcCtD
Rifabutin—Nausea—Docetaxel—stomach cancer	0.000309	0.000934	CcSEcCtD
Rifabutin—Feeling abnormal—Methotrexate—stomach cancer	0.000309	0.000934	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—stomach cancer	0.000309	0.000933	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000307	0.000927	CcSEcCtD
Rifabutin—Decreased appetite—Epirubicin—stomach cancer	0.000305	0.000922	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000303	0.000915	CcSEcCtD
Rifabutin—Pain—Epirubicin—stomach cancer	0.0003	0.000907	CcSEcCtD
Rifabutin—Nausea—Capecitabine—stomach cancer	0.000299	0.000904	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—stomach cancer	0.000297	0.000896	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—stomach cancer	0.000297	0.000896	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000296	0.000894	CcSEcCtD
Rifabutin—Insomnia—Doxorubicin—stomach cancer	0.000294	0.000887	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—stomach cancer	0.000292	0.000881	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—stomach cancer	0.00029	0.000875	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—stomach cancer	0.000289	0.000874	CcSEcCtD
Rifabutin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000287	0.000867	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—stomach cancer	0.000286	0.000864	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—stomach cancer	0.000282	0.000853	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000281	0.000847	CcSEcCtD
Rifabutin—Pain—Doxorubicin—stomach cancer	0.000278	0.000839	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—stomach cancer	0.000278	0.000838	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—stomach cancer	0.000278	0.000838	CcSEcCtD
Rifabutin—Hypersensitivity—Methotrexate—stomach cancer	0.000276	0.000835	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—stomach cancer	0.000269	0.000813	CcSEcCtD
Rifabutin—Feeling abnormal—Doxorubicin—stomach cancer	0.000268	0.000809	CcSEcCtD
Rifabutin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000266	0.000802	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—stomach cancer	0.000266	0.000802	CcSEcCtD
Rifabutin—Hypersensitivity—Epirubicin—stomach cancer	0.000259	0.000781	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—stomach cancer	0.000257	0.000776	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—stomach cancer	0.000257	0.000776	CcSEcCtD
Rifabutin—Diarrhoea—Methotrexate—stomach cancer	0.000257	0.000775	CcSEcCtD
Rifabutin—Asthenia—Epirubicin—stomach cancer	0.000252	0.000761	CcSEcCtD
Rifabutin—Pruritus—Epirubicin—stomach cancer	0.000248	0.00075	CcSEcCtD
Rifabutin—Diarrhoea—Epirubicin—stomach cancer	0.00024	0.000726	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—stomach cancer	0.000239	0.000723	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—stomach cancer	0.000239	0.00072	CcSEcCtD
Rifabutin—Rash—Methotrexate—stomach cancer	0.000237	0.000714	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—stomach cancer	0.000236	0.000714	CcSEcCtD
Rifabutin—Headache—Methotrexate—stomach cancer	0.000235	0.00071	CcSEcCtD
Rifabutin—Asthenia—Doxorubicin—stomach cancer	0.000233	0.000704	CcSEcCtD
Rifabutin—Pruritus—Doxorubicin—stomach cancer	0.00023	0.000694	CcSEcCtD
Rifabutin—Vomiting—Epirubicin—stomach cancer	0.000223	0.000674	CcSEcCtD
Rifabutin—Nausea—Methotrexate—stomach cancer	0.000223	0.000673	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—stomach cancer	0.000222	0.000671	CcSEcCtD
Rifabutin—Rash—Epirubicin—stomach cancer	0.000221	0.000669	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—stomach cancer	0.000221	0.000668	CcSEcCtD
Rifabutin—Headache—Epirubicin—stomach cancer	0.00022	0.000664	CcSEcCtD
Rifabutin—Nausea—Epirubicin—stomach cancer	0.000209	0.00063	CcSEcCtD
Rifabutin—Vomiting—Doxorubicin—stomach cancer	0.000207	0.000624	CcSEcCtD
Rifabutin—Rash—Doxorubicin—stomach cancer	0.000205	0.000619	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—stomach cancer	0.000205	0.000618	CcSEcCtD
Rifabutin—Headache—Doxorubicin—stomach cancer	0.000204	0.000615	CcSEcCtD
Rifabutin—Nausea—Doxorubicin—stomach cancer	0.000193	0.000583	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1B—stomach cancer	8.47e-05	0.000192	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SMAD4—stomach cancer	8.38e-05	0.00019	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTM1—stomach cancer	8.38e-05	0.00019	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	8.26e-05	0.000187	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ANXA1—stomach cancer	8.22e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FGFR2—stomach cancer	8.09e-05	0.000183	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—stomach cancer	8.08e-05	0.000183	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1B—stomach cancer	8.08e-05	0.000183	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ADRB1—stomach cancer	7.96e-05	0.00018	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FYN—stomach cancer	7.96e-05	0.00018	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ACAD8—stomach cancer	7.84e-05	0.000177	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—stomach cancer	7.83e-05	0.000177	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1A—stomach cancer	7.81e-05	0.000177	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	7.72e-05	0.000175	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—stomach cancer	7.7e-05	0.000174	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—JUN—stomach cancer	7.69e-05	0.000174	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	7.66e-05	0.000173	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERCC2—stomach cancer	7.65e-05	0.000173	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—stomach cancer	7.61e-05	0.000172	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RPS6—stomach cancer	7.6e-05	0.000172	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPP2R1A—stomach cancer	7.56e-05	0.000171	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—stomach cancer	7.53e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGFR2—stomach cancer	7.47e-05	0.000169	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1A—stomach cancer	7.45e-05	0.000169	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK3—stomach cancer	7.45e-05	0.000169	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTP1—stomach cancer	7.41e-05	0.000168	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IRS2—stomach cancer	7.41e-05	0.000168	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—stomach cancer	7.37e-05	0.000167	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—HMOX1—stomach cancer	7.31e-05	0.000165	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK8—stomach cancer	7.28e-05	0.000165	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—stomach cancer	7.25e-05	0.000164	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—stomach cancer	7.24e-05	0.000164	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	7.2e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK3—stomach cancer	7.2e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTHFR—stomach cancer	7.19e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK1—stomach cancer	7.09e-05	0.00016	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTP1—stomach cancer	7.04e-05	0.000159	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HBEGF—stomach cancer	6.99e-05	0.000158	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GMPR2—stomach cancer	6.99e-05	0.000158	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	6.94e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—stomach cancer	6.93e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TYMS—stomach cancer	6.89e-05	0.000156	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK1—stomach cancer	6.85e-05	0.000155	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—stomach cancer	6.85e-05	0.000155	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IRS2—stomach cancer	6.84e-05	0.000155	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PRKCB—stomach cancer	6.84e-05	0.000155	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTM1—stomach cancer	6.81e-05	0.000154	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6ST—stomach cancer	6.81e-05	0.000154	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	6.75e-05	0.000153	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	6.67e-05	0.000151	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK3—stomach cancer	6.66e-05	0.000151	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CAV1—stomach cancer	6.63e-05	0.00015	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOA1—stomach cancer	6.62e-05	0.00015	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—stomach cancer	6.52e-05	0.000148	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—stomach cancer	6.48e-05	0.000147	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTM1—stomach cancer	6.47e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—stomach cancer	6.47e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ADRB2—stomach cancer	6.45e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ERCC2—stomach cancer	6.41e-05	0.000145	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH3B—stomach cancer	6.39e-05	0.000145	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SUCLG1—stomach cancer	6.39e-05	0.000145	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	6.38e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK3—stomach cancer	6.35e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK1—stomach cancer	6.34e-05	0.000143	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PPP2R1A—stomach cancer	6.32e-05	0.000143	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6ST—stomach cancer	6.29e-05	0.000142	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CASP8—stomach cancer	6.09e-05	0.000138	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6R—stomach cancer	6.07e-05	0.000138	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ACAD8—stomach cancer	6.05e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK1—stomach cancer	6.05e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—stomach cancer	6.05e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APC—stomach cancer	6.04e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—stomach cancer	6.02e-05	0.000136	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—MTHFR—stomach cancer	6.02e-05	0.000136	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NDUFV1—stomach cancer	5.94e-05	0.000134	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NDUFS1—stomach cancer	5.94e-05	0.000134	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SMAD4—stomach cancer	5.87e-05	0.000133	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	5.81e-05	0.000131	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—stomach cancer	5.71e-05	0.000129	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6R—stomach cancer	5.61e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FYN—stomach cancer	5.57e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CAV1—stomach cancer	5.55e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOA1—stomach cancer	5.54e-05	0.000125	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—stomach cancer	5.5e-05	0.000124	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GMPR2—stomach cancer	5.39e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—stomach cancer	5.32e-05	0.00012	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PGLS—stomach cancer	5.3e-05	0.00012	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BLVRB—stomach cancer	5.3e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—stomach cancer	5.26e-05	0.000119	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SERPINE1—stomach cancer	5.25e-05	0.000119	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—stomach cancer	5.25e-05	0.000119	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGFR2—stomach cancer	5.23e-05	0.000118	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—stomach cancer	5.08e-05	0.000115	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RHOA—stomach cancer	5.07e-05	0.000115	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPAP2A—stomach cancer	5.05e-05	0.000114	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS3—stomach cancer	5.01e-05	0.000113	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH3B—stomach cancer	4.93e-05	0.000112	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.93e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—stomach cancer	4.88e-05	0.000111	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.86e-05	0.00011	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—stomach cancer	4.85e-05	0.00011	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IRS2—stomach cancer	4.79e-05	0.000108	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1B—stomach cancer	4.7e-05	0.000106	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—stomach cancer	4.69e-05	0.000106	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—stomach cancer	4.65e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CAV1—stomach cancer	4.64e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOA1—stomach cancer	4.63e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1B—stomach cancer	4.62e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—stomach cancer	4.59e-05	0.000104	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NDUFV1—stomach cancer	4.59e-05	0.000104	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NDUFS1—stomach cancer	4.59e-05	0.000104	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FBP1—stomach cancer	4.5e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA1—stomach cancer	4.5e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CKB—stomach cancer	4.5e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NDUFA2—stomach cancer	4.5e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—JUN—stomach cancer	4.48e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PRKCB—stomach cancer	4.42e-05	0.0001	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6ST—stomach cancer	4.4e-05	9.96e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—stomach cancer	4.39e-05	9.94e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1B—stomach cancer	4.34e-05	9.83e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1A—stomach cancer	4.34e-05	9.83e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK8—stomach cancer	4.24e-05	9.59e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLIN2—stomach cancer	4.23e-05	9.58e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APC—stomach cancer	4.23e-05	9.57e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NOS3—stomach cancer	4.2e-05	9.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA2—stomach cancer	4.12e-05	9.32e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BLVRB—stomach cancer	4.09e-05	9.25e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PGLS—stomach cancer	4.09e-05	9.25e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PGAM1—stomach cancer	4.01e-05	9.08e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NT5E—stomach cancer	4.01e-05	9.08e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1A—stomach cancer	4.01e-05	9.07e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6R—stomach cancer	3.93e-05	8.89e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.9e-05	8.82e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—stomach cancer	3.87e-05	8.77e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—stomach cancer	3.84e-05	8.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLCE1—stomach cancer	3.83e-05	8.67e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDH7A1—stomach cancer	3.83e-05	8.67e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK3—stomach cancer	3.7e-05	8.38e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SERPINE1—stomach cancer	3.68e-05	8.32e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—UMPS—stomach cancer	3.67e-05	8.31e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—stomach cancer	3.58e-05	8.1e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RHOA—stomach cancer	3.55e-05	8.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK1—stomach cancer	3.52e-05	7.97e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—stomach cancer	3.52e-05	7.97e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOS3—stomach cancer	3.51e-05	7.95e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CKB—stomach cancer	3.47e-05	7.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FBP1—stomach cancer	3.47e-05	7.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.47e-05	7.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA1—stomach cancer	3.47e-05	7.87e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK3—stomach cancer	3.42e-05	7.74e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PDHA1—stomach cancer	3.41e-05	7.72e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ECHS1—stomach cancer	3.41e-05	7.72e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—stomach cancer	3.33e-05	7.53e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—stomach cancer	3.32e-05	7.52e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—stomach cancer	3.28e-05	7.43e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLIN2—stomach cancer	3.27e-05	7.4e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK1—stomach cancer	3.25e-05	7.36e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—stomach cancer	3.25e-05	7.36e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMP—stomach cancer	3.21e-05	7.26e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FADS1—stomach cancer	3.21e-05	7.26e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA2—stomach cancer	3.18e-05	7.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—stomach cancer	3.11e-05	7.05e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PGAM1—stomach cancer	3.1e-05	7.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NT5E—stomach cancer	3.1e-05	7.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—stomach cancer	3.07e-05	6.95e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—stomach cancer	3.06e-05	6.92e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1B—stomach cancer	3.04e-05	6.88e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SREBF2—stomach cancer	3e-05	6.8e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—RORA—stomach cancer	2.97e-05	6.72e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.95e-05	6.69e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLCE1—stomach cancer	2.95e-05	6.69e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—stomach cancer	2.9e-05	6.57e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JUN—stomach cancer	2.9e-05	6.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UMPS—stomach cancer	2.83e-05	6.41e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—stomach cancer	2.83e-05	6.4e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—stomach cancer	2.82e-05	6.39e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—stomach cancer	2.82e-05	6.38e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1A—stomach cancer	2.81e-05	6.35e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDOB—stomach cancer	2.78e-05	6.3e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK8—stomach cancer	2.74e-05	6.2e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—stomach cancer	2.71e-05	6.13e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PDHA1—stomach cancer	2.63e-05	5.96e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ECHS1—stomach cancer	2.63e-05	5.96e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.62e-05	5.94e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.62e-05	5.92e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—stomach cancer	2.61e-05	5.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALOX5—stomach cancer	2.59e-05	5.85e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DPYD—stomach cancer	2.54e-05	5.76e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—stomach cancer	2.53e-05	5.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—stomach cancer	2.5e-05	5.67e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—stomach cancer	2.5e-05	5.66e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FADS1—stomach cancer	2.48e-05	5.6e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMP—stomach cancer	2.48e-05	5.6e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK3—stomach cancer	2.39e-05	5.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—stomach cancer	2.36e-05	5.35e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—stomach cancer	2.33e-05	5.27e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SREBF2—stomach cancer	2.32e-05	5.25e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.31e-05	5.22e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—RORA—stomach cancer	2.29e-05	5.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK1—stomach cancer	2.28e-05	5.15e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—stomach cancer	2.28e-05	5.15e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—stomach cancer	2.25e-05	5.09e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2A6—stomach cancer	2.22e-05	5.03e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKR1C3—stomach cancer	2.16e-05	4.9e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—stomach cancer	2.15e-05	4.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDOB—stomach cancer	2.15e-05	4.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO1—stomach cancer	2.11e-05	4.77e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.07e-05	4.69e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALOX5—stomach cancer	2e-05	4.52e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—stomach cancer	1.98e-05	4.47e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DPYD—stomach cancer	1.96e-05	4.44e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—stomach cancer	1.91e-05	4.33e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CD44—stomach cancer	1.87e-05	4.23e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—stomach cancer	1.83e-05	4.14e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.81e-05	4.11e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—stomach cancer	1.75e-05	3.96e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—stomach cancer	1.74e-05	3.93e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.72e-05	3.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.67e-05	3.78e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO1—stomach cancer	1.63e-05	3.68e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.59e-05	3.6e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—stomach cancer	1.56e-05	3.53e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMOX1—stomach cancer	1.54e-05	3.48e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMS—stomach cancer	1.45e-05	3.28e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CD44—stomach cancer	1.44e-05	3.27e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—stomach cancer	1.43e-05	3.24e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ERCC2—stomach cancer	1.35e-05	3.05e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—stomach cancer	1.27e-05	2.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.23e-05	2.78e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—stomach cancer	1.2e-05	2.72e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMOX1—stomach cancer	1.19e-05	2.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAV1—stomach cancer	1.17e-05	2.64e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA1—stomach cancer	1.17e-05	2.64e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMS—stomach cancer	1.12e-05	2.53e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.12e-05	2.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—stomach cancer	1.11e-05	2.5e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ERCC2—stomach cancer	1.04e-05	2.35e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—stomach cancer	1.03e-05	2.32e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—stomach cancer	9.77e-06	2.21e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—stomach cancer	9.23e-06	2.09e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAV1—stomach cancer	9.02e-06	2.04e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA1—stomach cancer	8.99e-06	2.04e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NOS3—stomach cancer	8.83e-06	2e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—stomach cancer	8.08e-06	1.83e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—stomach cancer	7.93e-06	1.79e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—stomach cancer	7.13e-06	1.61e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NOS3—stomach cancer	6.82e-06	1.54e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—stomach cancer	6.23e-06	1.41e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—stomach cancer	4.97e-06	1.13e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.84e-06	8.68e-06	CbGpPWpGaD
